Literature DB >> 16555318

Nonalcoholic fatty liver disease and liver transplantation.

Paul Angulo1.   

Abstract

Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurrence rate of disease. This paper reviews the prevalence of nonalcoholic fatty liver disease, its progressive potential, and the implications of this liver condition in both the pre- and post-liver transplantation setting. Copyright 2006 AASLD

Entities:  

Mesh:

Year:  2006        PMID: 16555318     DOI: 10.1002/lt.20738

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  37 in total

1.  Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Authors:  Michael Charlton; Anuradha Krishnan; Kimberly Viker; Schuyler Sanderson; Sophie Cazanave; Andrea McConico; Howard Masuoko; Gregory Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  Resolution of donor non-alcoholic fatty liver disease following liver transplantation.

Authors:  Andrew D Posner; Samuel T Sultan; Norann A Zaghloul; William S Twaddell; David A Bruno; Steven I Hanish; William R Hutson; Laci Hebert; Rolf N Barth; John C LaMattina
Journal:  Clin Transplant       Date:  2017-07-13       Impact factor: 2.863

3.  Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.

Authors:  Christopher D Anderson; Gundumi Upadhya; Kendra D Conzen; Jianlou Jia; Elizabeth M Brunt; Venkataswarup Tiriveedhi; Yan Xie; Sabarinathan Ramachandran; Thalachallour Mohanakumar; Nicholas O Davidson; William C Chapman
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

4.  Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Authors:  Vijay Subramanian; Anil B Seetharam; Neeta Vachharajani; Venkataswarup Tiriveedhi; Nataraju Angaswamy; Sabarinathan Ramachandran; Jeffrey S Crippin; Surendra Shenoy; William C Chapman; Thalachallour Mohanakumar; Christopher D Anderson
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

5.  Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?

Authors:  Michael Charlton
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 6.  Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery.

Authors:  Andrea Lazzati; Antonio Iannelli; Anne-Sophie Schneck; Anaïs Charles Nelson; Sandrine Katsahian; Jean Gugenheim; Daniel Azoulay
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

7.  Hepatobiliary quiz-6 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-06

8.  Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluation.

Authors:  Birju D Bhatt; Thresiamma Lukose; Abby B Siegel; Robert S Brown; Elizabeth C Verna
Journal:  J Gastrointest Oncol       Date:  2015-10

9.  The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.

Authors:  Kim H H Liss; Kyle S McCommis; Kari T Chambers; Terri A Pietka; George G Schweitzer; Sara L Park; Ilke Nalbantoglu; Carla J Weinheimer; Angela M Hall; Brian N Finck
Journal:  Liver Transpl       Date:  2018-07       Impact factor: 5.799

Review 10.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.